Briefing
Clinical evaluation of cancer signal origin prediction and diagnostic resolution following multi-cancer early detection testing.
Diagnostic evaluations were consistent with the predicted cancer signal origin in 30/39 (77%) cases. Diagnostic resolution was reached after initial evaluation in 32/39 (82%); the remaining 7 reached resolution after additional workup (3 with cancer, 4 without). Whole-body imaging was used in 27 cases and was equivocal or had no impact on resolution in 8/27 (30%).
- n: 39 participants with a cancer signal detected by both test versions
- Assay: targeted methylation MCED test with cancer-signal-origin prediction (PATHFINDER / Galleri lineage)